420 with CNW – Denmark Approves Bulk Medical Cannabis Exports

The Danish Ministry of Health has revealed that an executive order allowing local companies to export medical cannabis in bulk took effect on the first day of this year. This puts Denmark in pole position around the continent since many other countries are still staggering in their efforts to get medical cannabis programs running.

For example, the military is the only entity authorized to grow cannabis in Italy while Germany is yet to get its domestic cultivation program going.

Several foreign medical cannabis companies, including The Green Organic Dutchman and Canopy Growth have set foot in Denmark. Several reasons make this landlocked nation ideal for this nascent industry.

First, Denmark is close to Germany. Germany is regarded as the “golden goose” in Europe, so any company that can access the German medical cannabis market stands to make a fortune. It is also easy to access the rest of Europe from Denmark.

Secondly, Denmark has an advanced agricultural system that relies on technology to grow products that compete favorably on the continent and beyond. This shift to automation didn’t just happen by chance. The Danes realized that in order to compete with warmer countries in the region, automation was the way to go. This removed the reliance on human labor that was very expensive. Cannabis growers therefore stand to benefit from this rich agricultural heritage.

Thirdly, the government in Denmark is stable and supportive of the medical cannabis industry. This support was ably demonstrated when in just one year, medical cannabis was legalized, regulations were passed and exports were also permitted. Other countries take more than a year to hit just one of those milestones.

Additionally, utility rates in Denmark are one of the lowest on the continent. This is a big advantage to cannabis growers because electricity is one of the largest costs that they have to incur in order to grow marijuana indoors.

However, not everything favors the Danish cannabis industry.

For starters, many local doctors are skeptical about the medicinal benefits of cannabis and they have voiced their concerns. Denmark has responded to this by creating the Clinical Cannabis Forum in order to spread awareness about medical marijuana.

Secondly, several countries in the south have longer growing seasons and warmer weather in addition to abundant cheap labor. These include Malta, Portugal and Greece. Their products are likely to give Denmark a run for its money.

It remains to be seen how Danish technology will be harnessed to address those roadblocks that may reduce the shine on the allure of the industry. Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) and Plus Products Inc. (CSE: PLUS) wish Denmark all the best on its journey to become a player in the international medical cannabis industry.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Rhode Island Considers Using Medical Cannabis to Stop Opioid Dependency

The Department of Health in Rhode Island has scheduled a public hearing early next month to collect views about a petition that calls for cannabis to be used to help people wean off prescription opioids.

Prescription opioid overdoses were found to be responsible for the death of 336 people in 2016 while the number of such fatalities in 2017 was 323. From the start of 2018 to September 2018, the fatalities from prescription overdoses were 220.

The public hearing will take place on February 6 starting at 10a.m at the auditorium of the DOH. Thereafter the department will review the feedback that it collects from different stakeholders before reviewing the available medical literature on the use of medical cannabis instead of prescription opioids.

The Department of Health will also contact clinicians and different researchers in order to learn what their opinion is on this matter.

Finally, a definitive decision on the petition will be made by the Department of Health. The law stipulates that a final decision has to be made on such petitions within 180 days from the time that the petition was received. This means that a final decision should be made by April 15 since the petition was received in October last year.

If Rhode Island decides to approve the use of medical cannabis in the place of prescription opioids, the patients may most likely consume their cannabis as edibles. However, people will also be free to smoke it or apply it topically as an ointment.

The CDC estimates that countrywide, more than 72,000 people died from opioid overdoses in 2017 alone. That figure was 10 percent higher than the opioid fatalities recorded in 2016. There is no sign that this trend of opioid dependency and overdoses will slow down soon, so there is an urgent need to find ways to deal with the crisis.

The outcome of the petition in Rhode Island may well hold the key to turning the tide on this epidemic since there are indicators that cannabis can help people to deal with chronic pain. If Rhode Island proves that this is the case, then a major revolution will take shape starting with the states where medical cannabis is legal, and spreading to the others where medical cannabis is yet to be legalized. Who knows, the federal government may eventually rethink its position on medical cannabis.

For now, the focus is on the upcoming public hearing and the eventual decision that will be made. Industry players like Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) and Plus Products Inc. (CSE: PLUS) hope that the hearing and the analysis thereafter brings an outcome that is in the best interest of patients.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Benzinga Cannabis Capital Conference Will Bring Cannabis Visionaries and Investors Together

  • Presented by Benzinga, the upcoming cannabis conference will be held at the Eden Roc in Miami Beach, Florida; it is the go-to source event for investors who want the latest news and opportunities from the burgeoning sector
  • The conference will kick off on January 15 with an invite-only C-Suite retreat for cannabis operators; the audience will be just 100 C-Suite executives; a pre-retreat reception will be held the night prior
  • The conference will feature company presentations, networking receptions and an all-star lineup of knowledgeable keynote speakers talking about the global opportunities for cannabis

Benzinga Cannabis Capital Conference (CCC) will offer attendees a fast-paced comprehensive lineup of speed networking, a specially selected lineup of keynoters, corporate presentations for investors and a look at the future of cannabis internationally. It will be held January 15-16 at the Eden Roc in Miami Beach (www.BenzingaCannabisConference.com).

The attendee mix is expected to consist of 25 percent institutional investors, 20 percent retail investors, 40 percent public cannabis companies, 10 percent private cannabis companies and five percent media.

Reserve your place and book hotel rooms for CCC now at http://cnw.fm/42sPg. Be sure to learn more about how you can qualify for special discounted tickets and hotel rooms.

“Benzinga’s Cannabis Capital Conference brings together the crème de la crème of the cannabis world,” Neal Hamilton, vice president of marketing for Benzinga, stated in a recent press release. “Benzinga has long presided as a financial media leader, offering broad coverage relative to the cannabis space. We now bring that standout expertise to a live setting where entrepreneurs and investors can network, forge deals and learn from today’s top cannabis influencers, policymakers and innovators.”

CCC will showcase the following public and private companies:

  • AmeriCann Inc. (OTCQB: ACAN)
  • Aurora Cannabis Inc. (TSX: ACB) (NYSE: ACB)
  • Cannex Capital Holdings Inc. (CSE: CNNX) (OTCQX: CNXXF)
  • Harvest Health & Recreation Inc. (CSE: HARV)
  • CEDR HR Solutions
  • CuraLeaf Holdings Inc. (CSE: CURA)
  • DionyMed Brands Inc. (OTC: HMDEF)
  • Growcentia
  • iAnthus Capital Holdings Inc. (CSE: IAN) (OTCQX: ITHUF)
  • InMed Pharmaceuticals Inc. (OTCQX: IMLFF) (TSX: IN)
  • KushCo Holdings Inc. (OTCQB: KSHB)
  • LGC Capital Ltd. (TSX.V: LG)
  • Liberty Health Sciences Inc. (OTCQX: LHSIF)
  • MariMed Inc. (OTCQB: MRMD)
  • Medicine Man Technologies Inc. (OTCQX: MDCL)
  • Medipharm Labs Corp. (TSX.V: LABS)
  • MJ Freeway
  • New Frontier Data
  • Newstrike Brands Ltd. (TSX.V: HIP)
  • Plus Products Inc. (CSE: PLUS)
  • Pure Global Cannabis Inc. (OTC: PRCNF) (TSX.V: PURE)
  • Radicle Inc./Gage Cannabis
  • Starbuds/Compass Cannabis
  • Trulieve Cannabis Corp. (CSE: TRUL) (OTC: TCNNF)
  • Valens GroWorks Corp. (OTCQB: MYMSF)
  • Wayland Group Corp. (OTCQB: MRRCF) (CSE: WAYL)
  • High Tide Inc. (CSE: HITI)

For more information, visit the event’s website at www.BenzingaCannabisConference.com

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

CannabisNewsWire is at the epicenter of the Cannabis Revolution.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Cannabis Legalization Has Reduced Smuggling and Improved Border Security, Study Finds

A new study has shown that the legalization of marijuana in different states has reduced drug smuggling and made the Southern U.S. border safer. This research was conducted by the Cato Institute.

The Cato Institute analyzed data on how much marijuana has been seized by Border Patrol agents over time. Customs and Border Protection (CBP) regularly releases statistics about the different drugs that have been seized at the different ports of entry into the country.

The analysis shows that over a period of five years, the quantity of marijuana smuggled has reduced by a whopping 78 percent. Similarly, the amount of marijuana seized by each Border Patrol agent has reduced by an average of 70 percent.

Colorado and Washington were the pioneers of marijuana legalization, and there are nearly a dozen states that have now ended the prohibition of marijuana. Many more are set to follow suit in the coming years as ballot measures and legislative action is already in advanced stages in several states as this year ends.

The Cato analysis is timely since it comes at a time when the White House is pushing hard for the construction of a wall on a large section of the border with Mexico. In fact, disagreement over the border wall even caused a partial government shutdown that is still ongoing.

The analysis of smuggling data shows that building a wall at the Mexican border isn’t likely to reduce the rate (and quantity) of the drugs smuggled into the U.S. Remember, the number of Border Patrol agents was dramatically increased between 2003 and 2009, but the CBP seizures data didn’t show any decline in the per-agent marijuana seizures. Only legalization has resulted in such a reduction since most consumers are more comfortable buying their cannabis from regulated sources instead of taking a chance with the smuggled substance for which no quality controls are implemented.

It is also worth remembering that the U.S. government constructed hundreds of miles of border fencing at about the same time when it doubled the CBP workforce, but there was no change in the data on smuggling. It may therefore be reasonable to expect that the wall may not fare any better since the real reason for smuggling (the lack of legal marijuana in some states) hasn’t been addressed.

As for the different marijuana industry players like Plus Products Inc. (CSE: PLUS) and Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF), the Cato research is yet another piece of evidence that marijuana legalization has so many direct and indirect benefits.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Medical Marijuana May Soon Be Allowed in Federally Subsidized Housing

The New York and New Jersey regional officer of the Department of Housing and Urban Development (HUD), Lynne Patton, has revealed that there is a need to reconcile state and federal marijuana laws so that individuals who are using medical marijuana in locations where it is legal don’t risk losing federally subsidized housing.

She was reacting to media reports about a 78-year old man (John Flickner) who had been evicted from his apartment in Niagara Falls, New York due to his use of medical cannabis.

Lynne Patton went on to reveal that she was working to get Flickner back into permanent housing once more, as well as helping any other individuals in the same situation.

The good news is that John Flickner received a call from his former landlord asking him to retake his apartment shortly after Flickner’s case appeared in the media. The company owning that block of apartments also revealed that it was reconsidering its policy on medical marijuana. It was not clear whether the Department of Housing and Urban Development played a role in getting Flickner to return to his old apartment.

New York is expanding its medical cannabis program, and plans are underway to legalize recreational marijuana as well. These developments have raised concerns about what will happen to all those people who live in federally subsidized housing and want to use medical or recreational marijuana.

It should be remembered that President Clinton signed a law in 1998 barring landlords from having a tenant (new or existing) who uses an illegal substance, such as cannabis.

However, President Obama’s government wrote a memo in 2014 clarifying that landlords had the liberty to accept or reject (even evict) tenants who consume illegal substances. The eviction of Flickner was therefore done at the discretion of the landlord since there was no legal obligation for that action to be taken.

Good news may be on the way for people in federal housing regarding marijuana. This is because the Department of Housing and Urban Development (as hinted upon by Patton) is working to clear up the policy issues resulting from the difference between state and federal laws. In the meantime, Congress may act on the same issue either sooner or after HUD reconsiders its position formally.

Congresswoman Eleanor Holmes Norton, a Democrat from DC, introduced a bill that seeks to provide housing safeguards at the federal level for people using either medical or recreational marijuana in legal states.

Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF), Plus Products Inc. (CSE: PLUS) and others in the industry are saddened by the fact that an old man (John Flickner) had to undergo the distress of being evicted in order for the housing authorities to see that things need to change.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Australians to Conduct First Marijuana Clinical Trial for Brain Cancer

Two Australians, a naturopath and a neurosurgeon, have teamed up to conduct the first clinical trial in the world aimed at finding out whether cannabis can be used to treat glioblastoma, one of the most aggressive forms of brain cancer.

This type of cancer affects at least 1,000 individuals in Australia alone each year. Sadly, the majority of the patients diagnosed with glioblastoma die within one year and only 5 percent survive for five years after diagnosis.

Dr. Janet Schloss, a naturopath based in Brisbane, and Prof. Charlie Teo, a famous neurosurgeon, have teamed up to explore how patients can have better chances of surviving this cancer if medical cannabis is used alongside the conventional cancer treatments (chemo, radiotherapy and surgery).

The Australian researchers aren’t starting from zero. They have accessed studies conducted in Spain to the effect that medical cannabis inhibits the regrowth of brain tumors in animals. Some human studies have also shown that cannabis may help brain cancer patients to survive for longer.

This research only became possible after Australia made legal changes that permitted the use of some forms of cannabis for medical purposes in 2017. This legal step meant that researchers could now shift from just looking into the side-effects of cannabis consumption to studying how cannabis could be used as a medicine.

Dr. Schloss revealed that she was inspired to do this research after Spanish researchers used cannabis injections to reduce the size of brain tumors. Their research will focus on preventing the regrowth of the brain tumors because patients normally succumb to the condition when suppressed tumors regrow rapidly and cause the death of the patient.

For now, the researchers are recruiting study participants. This stage will be followed by a clinical trial lasting three months in which patients will consume 2ml of cannabis oil each night. The oil was carefully formulated by BioCeuticals to contain as little THC as possible in order to prevent the patients from waking up groggy, or affecting their sleep.

The researchers will document the extent to which cannabis supports the conventional treatments used to treat glioblastoma. The research is being conducted at the Endeavour College of Natural Health, and the New South Wales Ministry of Health has approved the clinical trial. The researchers hope that their findings will increase the options available to the patients who desperately need help in fighting this serious type of cancer. The cannabis community, including companies like Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) and Plus Products Inc. (CSE: PLUS), are waiting with bated breath for the outcome of this groundbreaking research.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – California Judge Rules in Favor of Marijuana Home Growers

When California legalized recreational cannabis, it allowed people to grow a maximum of six plants for their own use. The state permitted cities and other local authorities to pass their own additional ordinances or regulations to implement the law passed at state level. Some cities, such as Fontana, took this liberty as a chance for them to put such severe restrictions that various aspects of state law, such as home growing, would practically be impossible within their jurisdictions. Someone sued, and a judge has ruled striking down several sections of the Fontana ordinance on cannabis.

The issues in contention were the strict inspection and permitting process for anyone who wanted to grow cannabis at home for his or her own use.

For example, each applicant for a permit had to pay in order to have a background check performed before the home growing license could be issued. The annual permit fees were also high, starting at $411 for the year in which the application was made and then $253 for each year that an approved applicant wanted to continue having a permit to grow marijuana at home.

In addition, applicants had to allow a city official to come and inspect their residence in order to confirm that the property conformed to all city requirements.

The plaintiff argued that the restrictions went against the spirit of the state law which legalized recreational cannabis. For example, the ordinance in Fontana allowed the city to deny an applicant the license to grow marijuana if that applicant had any outstanding city dues.

Additionally, state law didn’t envisage any permitting process for anyone who wanted to grow cannabis at their residence.

It is not surprising that not a single permit has been issued to a Fontana resident to grow cannabis at home so far.

David Cohn, a superior court judge, agreed with the plaintiff and struck down several sections of the city ordinance for being in violation of state law. He explained that the city could not claim to be implementing federal law since it wasn’t a federal entity.

What are the implications of this judgment delivered in the first week of this month? The city authorities have not revealed whether they will appeal against the judgment, but indicators are that they may modify the ordinance while leaving as many restrictions as they can.

Several local authorities have tried to do whatever they can to frustrate marijuana legalization in their jurisdictions. This judgment is likely to make them think twice before they pass restrictions which are “unreasonable” and go against the intention of the enabling state law.

The judgment is also unlikely to be used as a precedent in other cases since it was made by a lower court. However, the case may give other residents the courage to challenge the laws in other localities in case those laws make it very hard for them to enjoy the freedoms given under state law.

As Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) and Plus Products Inc. (CSE: PLUS) already know, plenty of time is required to change the mindset of various stakeholders after cannabis is legalized. The prayer is that the adjustment period doesn’t drag on for too long.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Documentary About Medical Cannabis Benefits Released

A new film focusing on how medical cannabis has helped children suffering from cancer has been released. The film is titled “Weed the People”.

Abby Esptein, the director of the movie, said that the purpose of the film was to address the stigma directed at medical marijuana.

The documentary shows babies whose lives are literary fading away as a result of undergoing chemo and other conventional forms of cancer treatment. However, the use of medical cannabis transforms the lives of those babies and saves many of them from imminent death.

The movie traces the journey of different parents who are battling to access medical marijuana in order to save their kids’ lives from the ravages of cancer.

The timing of the movie seems to have been perfect given that the FDA recently approved a cannabis-derived drug for the treatment of epilepsy. Such regulatory approval seems to go against the long-held attitude towards cannabis as something that doesn’t possess any medical value.

Rickie Lake, the producer of “Weed the People” says cannabis was a medicine for thousands of years and it has only been a restricted substance for about 80 years. That restriction was the result of people being brainwashed to abandon the use of a plant with nearly countless benefits, the producer added.

The filmmakers revealed that their project has been in the making for the past five years, so no one should imagine that the film was motivated by the recent wave of public opinion in favor of medical marijuana.

They hope that the film will provide the missing link which will convince the general public about the usefulness of cannabis. They also hope that the movie will help to propel understanding of medical cannabis, and possibly address the opioid epidemic in the country.

In the film, parents choose medical marijuana instead of prescription meds. The results show how right those parents were since their kids improve remarkably while they are on medical cannabis treatment.

The producer of “Weed the People” says that her interest is to create awareness about the different treatment options available to patients. Whether or not those patients opt for medical marijuana is of little interest to her as long as any decision that a patient or caregiver makes is an informed one.

After watching the stories of the approximately half a dozen children on medical marijuana, one is left asking himself or herself why the American federal government is so opposed to legalizing a substance which is having such untold benefits to kids with cancer. You can bet your last dollar that Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) and Plus Products Inc. (CSE: PLUS) are asking themselves that same question.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Michigan Provides Online Tools for Medical Marijuana Patients

The state of Michigan has taken additional steps towards improving access to its medical marijuana program. Patients now have a number of online tools that they can use to register and get certification cards which permit them to access medical marijuana.

The Department of Licensing and Regulatory Affairs in Michigan announced a few days ago that any patient who doesn’t have a caregiver can simply go online and apply for an identification card from the medical marijuana registry.

Such patients can also monitor the status of their online application by logging into a secure account created for them when they launch their application for the identification card.

The state also plans to make it possible for those patients who don’t have a caregiver to use the same online tool when it is time for them to renew their identification card for the medical marijuana program.

Previously, patients were expected to be present (in person) at an authorized office where cards could be applied for or renewed. Experience has shown that the old system was unnecessarily burdensome for particularly those patients who lived alone or whose condition made it hard for them to move from their homes.

It will also be possible for patients change their address information, ask for replacement cards or withdraw from the program. These features are still being added to the online tool.

Doctors have also been given an opportunity to register for a secure online account. The doctors who take up that offer will use that secure account to certify that their patients have been recommended to use medical marijuana. This will reduce the need for patients to get hard copy recommendation letters to use during the registration process for the medical cannabis program.

Michigan residents voted to legalize medical marijuana in 2008. Since then, the state has been tweaking its methods of administering the program so that patients get the care they need in a way that doesn’t risk the confidentiality of those patients or endanger the public.

The online app is the latest addition to the measures intended to deliver efficient services to qualifying patients. A quick scan of the information available at the website of the Licensing and Regulatory Affairs department shows that patients should typically wait for a maximum of five weeks for their online applications to be processed.

One can then call a given number in case they have waited for more than five weeks but haven’t received any feedback from the department.

Marijuana industry players like Phivida Holdings Inc. (CSE: VIDA) OTC: PHVAF) and Plus Products Inc. (CSE: PLUS) definitely applaud the measures being instituted to remove any inconveniences suffered by patients as they try to access medical marijuana.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com